…management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022;81(6):768–79…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 153 of 2459…ritical to avoid exacerbating existing inequities. For example, prostate cancer incidence is higher in black patients.55 Further, incidence, pa…
…e users), we found some increased risks of MM, particularly for alachlor (1.41 [0.88-2.26]), metolachlor (1.44 [0.90-2.31])) and napropa…
… endocrine disrupting properties, but few studies have examined breast cancer risk in relation to specific active ingredients. Existing studi…
…e was a 43% increase in self-reported QOL using EQ-VAS (EuroQoL Visual Analogue Scale) tool and a reduction in depression by 57% using the HADS (Hosp…
…iliary atresia, one unknown aetiology) resulting in a perihilar cholangiocarcinoma incidence of 13% (5/38) in cholangiopathy explants. This is sig…
…r histological).All patients were treated with a combination of ursodeoxycholic acid (UDCA) and immunosuppressive therapy (corticosteroids with or w…
…8]); and 62.1% as encephalopathy (9 years [6–11.75]).Conclusion Cryptogenic cirrhosis is frequently observed and may significantly contribute to the …
…vasive profile make it an effective bridging or primary therapy.Botulinum toxin A is a safe, effective, and repeatable intervention in select pae…
…ve public health interventions.Objective To assess the trend of myopia prevalence in Europe over the last century, examine the role of…
…ciation class or heart failure medications was made.Conclusions Cardiac cachexia is associated with a higher risk of all-cause mortality and MAC…
…ine the MCID in arthralgia, we studied 97 patients treated with methotrexate in the TREAT EARLIER trial with HAQ-DI data at baseline and 12 …